In short
Clinical trials investigating Sodium Glycerophosphate are being used in studies of surgical nutrition support. These trials look at outcomes such as muscle loss and infectious complications after major surgery. The target groups include people after oesophagectomy and people having major emergency abdominal surgery.
Key points
- Clinical trials investigating Sodium Glycerophosphate are focused on nutrition support after major surgery. One Phase 3 trial studies patients after oesophagectomy and measures muscle size by CT scan. Another Phase 3 trial studies patients after major emergency abdominal surgery and looks at infectious complications during admission. Both trials are authorised and are testing how nutrition strategies affect recovery. The target populations are surgical patients who may need extra nutrition support during hospital care.
Trial overview
The source data includes two authorised interventional studies involving Sodium Glycerophosphate-related nutrition support in surgical patients. One study is titled “Route of nutrition and muscle wasting after oesophagectomy,” and the other is titled “Early versus postponed supplementary parenteral nutrition after major emergency abdominal surgery.”
Both studies are Phase 3 trials, which means they are testing the approach in larger patient groups and focusing on real clinical results after surgery.
Patient groups studied
One trial studies people after oesophagectomy, which is surgery to remove part or all of the food pipe. The trial aims to understand how the route of nutrition affects cachexia, a term used for severe body wasting or loss of weight and muscle during illness.
The second trial studies people after major emergency abdominal surgery, meaning urgent surgery in the abdomen. This study compares early and postponed supplementary parenteral nutrition, which is extra nutrition given through a vein when regular feeding is not enough.
The trial data does not give detailed inclusion or exclusion rules, so the main target groups are the surgical patients named in each study title and condition field.
Trial design and phase
Both studies are listed as interventional, which means researchers assign a nutrition strategy and then measure the effect. This is different from an observational study, where researchers only watch what happens without assigning treatment.
The first trial has an enrollment of 38 participants, while the second trial plans to enroll 342 participants. These numbers show that the studies are looking at both a smaller focused group and a larger group for comparison.
Both studies are marked Authorised, which means they have been approved in the source record.
Main outcomes being measured
The first trial measures the mean difference in muscle size using a CT-scan from before surgery to 10 days after surgery. This outcome is meant to show whether the nutrition route affects muscle loss after oesophagectomy.
The second trial measures the reduction in the rate of infectious complications during admission. In simple terms, the study wants to know whether giving supplementary parenteral nutrition earlier or later changes the chance of infection while the patient is in hospital.
What the results may mean
These trials are not designed to describe Sodium Glycerophosphate as a medicine in general; they are studying how nutrition support strategies perform in surgical recovery. The main question is whether different nutrition routes or timing can help reduce muscle wasting or infections after major surgery.
If the trials show benefit, the results could support better nutrition planning for patients recovering from oesophagectomy or major emergency abdominal surgery.